Checkpoint Therapeutics Inc (NASDAQ:CKPT)
| 3.27 Delayed Data As of Dec 08 |  +0.06 / +1.86%Today’s Change | 1.30 Today|||52-Week Range 8.15 | -36.01% Year-to-Date |
Latest CKPT News | Press Releases
No recent news for Checkpoint Therapeutics Inc.
Today’s Trading
| Previous close | 3.23 |
| Today’s open | 3.26 |
| Day’s range | 3.06 - 3.34 |
| Volume | 782,677 |
| Average volume (3 months) | 356,704 |
| Market cap | $76.9M |
Data as of 3:59pm ET, 12/08/2023
Growth & Valuation
| Earnings growth (last year) | +4.91% |
| Earnings growth (this year) | +51.59% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -28.36% |
| P/E ratio | NM |
| Price/Sales | 235.15 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| EGRXEagle Pharmaceutical... | -0.16 | -2.66% |
| ---- | ||
| EYENEyenovia Inc | +0.23 | +14.47% |
| --W World Corp | 0.00 | 0.00% |
Data as of 3:59pm ET, 12/08/2023
Financials
| Next reporting date | March 14, 2024 |
| EPS forecast (this quarter) | -$0.96 |
| Annual revenue (last year) | $192.0K |
| Annual profit (last year) | -$62.6M |
| Net profit margin | -32,616.67% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Waltham, Massachusetts |
Forecasts
